OurCrowd

A better way to invest in startups.

In the News: What’s next after Israel’s biggest diplomatic event in its history?

by

Israel hosted its biggest diplomatic event in its history last week: delegations from 49 countries, including 41 heads of state, gathered in Jerusalem for The Fifth World Holocaust Forum.

We are looking forward to welcoming thousands more tech and investment leaders from around the globe this February 13th for the 2020 OurCrowd Global Investor Summit to share, celebrate and invest in Israeli and global tech. Space is limited; tickets for active OurCrowd members are guaranteed upon registration. Apply now. 

Happy Chinese New Year from OurCrowd: We want to wish our Chinese friends all over the world a healthy, happy, and prosperous year ahead. 

Denes Chinese New Year

[Read more…]

In the News: Israel’s exit value grew 800% in the last decade

by

OurCrowd’s portfolio is heating up: Alpha Tau launches their first US cancer trial; AgTech company CropX acquires the startup CropMetrics (cloud and sensor-based tech that provides irrigation timing recommendations to farmers); and great news for Zebra Medical Vision: Ohad Arazi joins as CEO, Amnon Shashua joins as a new investor – congrats to our brilliant chairman Eyal Gura and team.

Trusona raises $20 million to bring passwordless authentication to more businesses – OurCrowd was happy to participate in the round.

Watch my interview from the SALT Abu Dhabi conference, where I was the first Israeli VC to speak publicly in the Gulf. 

Jon SALT

[Read more…]

In the News: Your weekly roundup from the desk of Jon Medved

by

Are you with us this week at the J.P. Morgan Healthcare Conference in San Francisco? Meet OurCrowd’s medical portfolio, including 16 startups creating revolutionary solutions in areas including cancer treatment, blood testing, wound care, diabetes management, medical cannabis, care for older adults, and more. Schedule a meeting.

jp morgan health

Venture capital has been perhaps the best performing asset class over the last 25 years. The problem is that most people can’t access it… So where do people go to actually get into this VC bonanza? The answer is, they come here to OurCrowd, where we invite the investor to not just invest with us in the company but to help *grow* the company… Come see it in person at the 2020 OurCrowd Global Investor Summit on February 13th and meet thousands of your colleagues, and see hundreds of startups. Looking forward to seeing you there…

Jon Get Started

[Read more…]

In the News: Kicking off 2020 with big wins, including new tender to operate medical cannabis incubator

by

We ended off 2019 with exciting news for OurCrowd and the Israeli ecosystem. Israeli tech raised over $350M in December, and raised a record $8.19B in 2019, easily surpassing the $6.4B raised in 2018, which was itself a record.

In OurCrowd’s fifth incubator win, the consortium consisting of OurCrowd, Perrigo and BOL Pharma, won the Israeli government tender to operate CanNegev, a medical cannabis incubator that will be located in Yeruham, in the south of Israel. This will be the world’s first government-supported medical cannabis technology incubator. 

As I told NoCamels, in this past decade, the Israeli tech ecosystem came into its own. What was interesting, full of potential and a promising phenomenon, became a powerhouse juggernaut that everybody in the world now has recognized.

A decade ago, getting to $1 billion in equity crowdfunded assets was but a dream. I was humbled to be featured as one of 17 Israelis that shaped the decade.

[Read more…]

In the News: Intel acquires Habana Labs, OurCrowd in New Zealand, & more

by

It’s been an active week for us as we begin the global expansion of our incubator business…..with our first international win, in New Zealand – hotbed of agtech/foodtech together with our partners Sprout, Finistere, Fonterra, and Gallagher….

In an exciting exit, Intel acquires Habana Labs for $2B. This news is obviously very positive for other companies in the AI accelerator chip business. Hailo, an OurCrowd portfolio company in which we are currently re-investing, is in this space with its edge devices which — according to Hailo — can now run deep learning applications at full scale more efficiently, effectively, and sustainably than traditional solutions, while significantly lowering costs.

Great news from the SEC, proposing to make private investments (like OurCrowd) more accessible to the broader community. Kudos to Chairman Clayton and team….Read more on TechCrunch. [Read more…]

In the News: Were we right about 2019? + What’s coming in 2020?

by

It was a pleasure to be hosted at the SALT conference in Abu Dhabi, where, amongst other topics, we discussed startup ecosystems ranging from UAE, USA, Israel and beyond. I was one of the first Israeli VCs to speak openly in an investor conference in the Gulf, and I was thrilled to see the enthusiasm among investors for cooperation with Israel.

SALT conference

Up next: As we wrap up 2019, we examine what’s next for tech in 2020. Each year we predict 10 impactful tech trends; were we right about last year? Review what was predicted for 2019, and sign up to see live, in-person what we anticipate next, at the 2020 OurCrowd Global Investor Summit this February 13th in Jerusalem. Apply now.

General summit gif

[Read more…]

In the News: FDA clearance, Fox News, and the UN Assembly votes with Israel on AgTech

by

We are incredibly proud of Sight Diagnostics for receiving FDA clearance for its OLO blood analyzer; OLO leverages AI with a revolutionary method to “digitize” blood, allowing patients to receive blood test results within minutes at the point-of-care, and with just a finger-prick. OurCrowd has been very excited about Sight Diagnostics from early on, and we are looking forward to celebrating continued innovation and success together.

Over the weekend on Fox Business News, Stifel CEO Ron Kruszewski explained why the investment banking firm partnered with OurCrowd. Watch here.

Stifel CEO on FOX

In other news, 147 nations in the UN General Assembly voted in favor of an Israel initiated resolution to help improve access to agtech capabilities for developing countries. This is another reason why we are so glad to back Israeli agtech companies like Consumer Physics, CropX, Taranis, Tevel, and more.

[Read more…]

In the News: Israeli tech made up 9% of TIME’s 2019 Best Inventions

by

TIME Magazine gets it: Israeli companies made up 9% of their top 100 leading inventions for 2019; but who’s surprised? Startup Nation’s tech ecosystem makes up for the lack of Israel’s population size with our abundance of brain power, entrepreneurial zeal and hutzpah. Plus, three of the selections are companies we proudly count in OurCrowd’s portfolio… Congrats to Lemonade, TytoCare and Intuition Robotics!

Exciting news for Alpha Tau: Following its clinical trial, the company announced the publication of exceptional data from Alpha DaRT, its novel alpha radiotherapy for solid tumors, which achieved a 78.6% complete response rate in management of challenging squamous cell carcinoma tumors. New clinical trials are planned for pancreatic cancer, breast cancer, prostate cancer and vulva cancer.

Startup Nation and beyond

This groundbreaking OurCrowd-backed company is paving the way to save more lives…Zebra Medical gets FDA nod for device that detects water in lungs.

One of our newest mobility investments, Cartica, was just described as a ‘leap forward’ for autonomous vehicles. Herman Trend Alert noted that Cartica represents the “next generation of AI mobility solutions” whose “goal is to decrease road accidents worldwide.” Thanks to these futurists for giving “kudos to the Israeli venture capital group OurCrowd and to the automotive executives smart enough to support this development.”

Cartica is a 'leap forward'

The race for protein: How Israel can lead the race for developing the food of the future.

[Read more…]

HTML Snippets Powered By : XYZScripts.com